Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

Change Symbol: Lookup Trade Now

Emisphere Technologies | Company Snapshot

  • Vol:
  • Last Trade:

EMISPHERE TECHNOLOGIES INC.

Emisphere Technologies is a biopharmaceutical company focused on the development of a family of oral heparin products; the application of proprietary synthetic chemical compounds to serve as carriers to facilitate the transport of therapeutic macromolecules and other compounds across biological membranes; and the development, in conjunction with the company's pharmaceutical collaborators, of oral formulations of selected therapeutic macromolecules.


Symbol: EMIS
Exchange(s): OTCBB
Industry: Consumer Products (Biotechnology & Pharmaceuticals)
5-Star Rating:
ANNUAL FINANCIALS
  Dec 31, 2008
12 Months
us$
Dec 31, 2007
12 Months
us$
Dec 31, 2006
12 Months
us$
3Yr.
Growth
% Change
Total Revenue ($000) 250 4,070 7,250 -58.67
Earnings before Interest & Tax ($000) -21,430 -14,310 -39,430 N/A
Profit/Loss ($000) -24,380 -16,920 -41,760 N/A
Earnings per Share -0.80 -0.58 -1.58 N/A
Total Assets ($000) 10,170 19,480 28,090 -18.78
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity 96.19 171.17 397.90  
Employees N/A N/A N/A  
 
Trailing 12 Month Results
  12 Months ended
Dec 31, 2009,us$
12 Months ended
Dec 31, 2008,us$
%Change
Total Revenue ($000) N/A 240 N/A
Profit/Loss ($000) N/A -24,380 N/A
Earnings per Share N/A -0.80 N/A
Dividends Per Share 0.00 0.00
Number of Shares 42,070,000 30,340,000  
 
COMPANY INFORMATION
Key Personnel
CEO: Michael V. Novinski, Presi.; C.E.O.
CFO: Michael R. Garone, C.F.O.
 
Contact Information
Address: 240 Cedar Knolls Road,
Suite 200,
Cedar Knolls,
NJ,
07927
Phone: 914-347-2220
Fax: 914-347-2498
Web Address: www.emisphere.com
E-Mail : Info@Emisphere.com
 
Incorporation: United States 
 
Securities: EMIS-Q2
 
Top Companies in Biotechnology & Pharmaceuticals (Selected by Assets)
Pfizer Sanofi-Aventis Novartis AG
Johnson & Johnson GlaxoSmithKline PLC Astrazeneca PLC
Merck & Company Abbott Labs Amgen
 


Zacks Investment Research Financial data is provided by Zacks Investment Research.
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor. Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.

Back to top